SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Boden Robert)
 

Search: WFRF:(Boden Robert) > Treatment-resistant...

Treatment-resistant depression as risk factor for substance use disorders : a nation-wide register-based cohort study

Brenner, Philip (author)
Karolinska Institutet
Brandt, Lena (author)
Karolinska Institutet
Li, Gang (author)
Janssen Res & Dev LLC, Titusville, NJ USA
show more...
DiBernardo, Allitia (author)
Janssen Res & Dev LLC, Titusville, NJ USA
Bodén, Robert, 1973- (author)
Uppsala universitet,Ekselius: Psykiatri,Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden
Reutfors, Johan (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2019-04-15
2019
English.
In: Addiction. - : Wiley. - 0965-2140 .- 1360-0443. ; 114:7, s. 1274-1282
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and aims Treatment-resistant depression (TRD) is common among patients with major depressive disorder (MDD). MDD may increase the risk for developing substance use disorders (SUD). The aim of this study was to investigate the risk for developing SUD among patients with TRD compared with other depressed patients.Design Observational cohort study.Setting Nation-wide governmental health registers in Sweden.Participants All patients aged 18-69 years with an MDD diagnosis in specialized health care who had received at least one antidepressant prescription during 2006-14 were identified. Patients with at least three treatment trials within a single depressive episode were classified with TRD.Measurements Patients with TRD were compared with the whole MDD cohort regarding risk for obtaining a SUD diagnosis or medication using survival analyses adjusted for socio-demographics and comorbidities.Findings Of 121 669 MDD patients, 13% were classified with TRD. Among the patients without any history of SUD, patients with TRD had a risk increase for any SUD both ≤ 1 and > 1 year after antidepressant initiation [> 1 year hazard ratio (HR) = 1.4; 95% confidence interval (CI) = 1.3-1.5]. Risks were elevated for the subcategories of opioid (HR = 1.9, 95% CI = 1.4-2.5) and sedative SUD (HR = 2.7, 95% CI = 2.2-3.2). Patients with a history of SUD had a risk increase for any SUD ≤ 1 year after start of treatment (HR = 1.2, 95% CI = 1.1-1.4), and both ≤ 1 year and > 1 year for sedative (> 1 year HR = 2.0, 95% CI = 1.3-3.0) and multiple substance SUD (HR = 1.9, 95% CI = 1.4-2.5).Conclusions Patients with treatment-resistant depression may be at greater risk for substance use disorders compared with other patients with major depressive disorder. Patterns may differ for patients with and without a history of substance use disorders, and for different categories of substance use disorder.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Beroendelära (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Substance Abuse (hsv//eng)

Keyword

Addiction
alcoholism
antidepressants
depressive disorder
epidemiology
opioid-related disorders
treatment-resistant

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Addiction (Search for host publication in LIBRIS)

To the university's database

Find more in SwePub

By the author/editor
Brenner, Philip
Brandt, Lena
Li, Gang
DiBernardo, Alli ...
Bodén, Robert, 1 ...
Reutfors, Johan
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Psychiatry
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Health Sciences
and Substance Abuse
Articles in the publication
Addiction
By the university
Uppsala University
Karolinska Institutet

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view